Beranda › Kanker Prostat › Colorado › Colorado Springs
Uji klinis Kanker Prostat di Colorado Springs, CO
12 studi untuk Kanker Prostat mencari peserta di lokasi sekitar Colorado Springs (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Menerima pesertaFase 3
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Menerima pesertaFase 2
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Menerima pesertaFase 1/2
- Rocky Mountain Cancer Center, Colorado Springs
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Menerima pesertaFase 3
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Menerima pesertaFase 2
- Rocky Mountain Cancer Center, Colorado Springs
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Menerima pesertaFase 3
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Menerima pesertaFase 3
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- UCHealth Memorial Hospital Central, Colorado Springs
- dan 2 lainnya
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Menerima pesertaFase 1
- Rocky Mountain Cancer Center, Colorado Springs
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients
Menerima pesertaFase awal 1
- UCHealth-Southern Colorado, Colorado Springs
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Menerima pesertaFase 2
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- Saint Francis Cancer Center, Colorado Springs
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Menerima pesertaFase 3
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
Uji klinis Kanker Prostat di kota lain
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN43 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Studi lain di Colorado Springs
- Kolitis Ulseratif14 studi
- Penyakit Crohn13 studi
- Kanker Paru Non-Sel Kecil11 studi
- Kanker Paru8 studi
- Kanker Payudara7 studi
- Asma6 studi
- Kanker Kolon6 studi
- Kanker Kolorektal6 studi
- Kanker Rektum4 studi
- Gangguan Somnolen Berlebih4 studi
- Penyakit Radang Usus4 studi
- Karsinoma Sel Skuamosa Kepala dan Leher4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.